NCT01743950 2026-03-25A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With BevacizumabUniversity of Wisconsin, MadisonPhase 2 Terminated49 enrolled 19 charts
NCT03661723 2024-09-19Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent GlioblastomaDana-Farber Cancer InstitutePhase 2 Completed60 enrolled 23 charts